Confirming your payment

Skip to content

Practice Questions · Question 10 of 30

Three children, P, Q and R, have adenosine deaminase (ADA) deficiency.

Question 104 marksHard

Three children, P, Q and R, have adenosine deaminase (ADA) deficiency. The disorder is caused by deletion of the gene for ADA, an enzyme that is crucial for the immune system to function. The children are treated differently:

  • Child P receives a bone marrow transplant.
  • Child Q receives enzyme replacement therapy.
  • Child R receives gene therapy using lymphocytes taken from her own blood.

(a) What exactly is given to child Q, and what is given to child R? How does this decide which cells supply the functional ADA? (1)

(b) Some time after her treatment, child R is asked to come back for another infusion. Explain why. (1)

(c) The doctor says that none of the three treatments is a permanent cure. How could a permanent cure be achieved, and why would it last? (2)